Novel transcript, antisense to NLRC4 (ENSG00000289727)

This entry refers to a long non-coding RNA (lncRNA) annotated as “novel transcript, antisense to NLRC4” (ENSG00000289727). It is not a protein, enzyme, receptor, or therapeutic drug target, but an RNA molecule transcribed from the DNA strand opposite the NLRC4 gene locus. Its function is not specifically characterized, but antisense transcripts are broadly known to regulate gene expression through mechanisms such as transcriptional interference, chromatin remodeling, and RNA-RNA interactions[1][3]. There is no evidence suggesting therapeutic relevance, disease association, or drug interaction for ENSG00000289727 specifically. Its naming as a “novel transcript” and the lack of functional annotation or characterization in reputable databases suggest that it may be a predicted or incompletely validated transcript. As such, it is not recognized as a canonical therapeutic target, and returning “true” for is_incorrect reflects its absence from standard target catalogs and lack of direct pharmacological or biomarker relevance. If a standardized target structure is required, this entry does not map cleanly onto canonical target entities like receptors, enzymes, or established non-coding RNA drug targets, and the information is too limited or preliminary for structured therapeutic curation as a classic “target.”

Other names

Novel transcript antisense to NLRC4ENSG00000289727